These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 34970150)

  • 1. Mechanisms Underlying the Antidiabetic Activities of Polyphenolic Compounds: A Review.
    Nie T; Cooper GJS
    Front Pharmacol; 2021; 12():798329. PubMed ID: 34970150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unfolding Novel Mechanisms of Polyphenol Flavonoids for Better Glycaemic Control: Targeting Pancreatic Islet Amyloid Polypeptide (IAPP).
    Sequeira IR; Poppitt SD
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28754022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role and Cytotoxicity of Amylin and Protection of Pancreatic Islet β-Cells from Amylin Cytotoxicity.
    Kiriyama Y; Nochi H
    Cells; 2018 Aug; 7(8):. PubMed ID: 30082607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus.
    Jeong HR; An SS
    Clin Interv Aging; 2015; 10():1873-9. PubMed ID: 26604727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chaperone proteins HSP70, HSP40/DnaJ and GRP78/BiP suppress misfolding and formation of β-sheet-containing aggregates by human amylin: a potential role for defective chaperone biology in Type 2 diabetes.
    Chien V; Aitken JF; Zhang S; Buchanan CM; Hickey A; Brittain T; Cooper GJ; Loomes KM
    Biochem J; 2010 Nov; 432(1):113-21. PubMed ID: 20735358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rutin suppresses human-amylin/hIAPP misfolding and oligomer formation in-vitro, and ameliorates diabetes and its impacts in human-amylin/hIAPP transgenic mice.
    Aitken JF; Loomes KM; Riba-Garcia I; Unwin RD; Prijic G; Phillips AS; Phillips ARJ; Wu D; Poppitt SD; Ding K; Barran PE; Dowsey AW; Cooper GJS
    Biochem Biophys Res Commun; 2017 Jan; 482(4):625-631. PubMed ID: 27865831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation into the potential action of polyphenols against human Islet Amyloid Polypeptide aggregation in type 2 diabetes.
    Mahboob A; Senevirathne DKL; Paul P; Nabi F; Khan RH; Chaari A
    Int J Biol Macromol; 2023 Jan; 225():318-350. PubMed ID: 36400215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis signal regulating kinase-1 and NADPH oxidase mediate human amylin evoked redox stress and apoptosis in pancreatic beta-cells.
    Singh S; Bhowmick DC; Pany S; Joe M; Zaghlula N; Jeremic AM
    Biochim Biophys Acta Biomembr; 2018 Sep; 1860(9):1721-1733. PubMed ID: 29627323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The β-cell assassin: IAPP cytotoxicity.
    Raleigh D; Zhang X; Hastoy B; Clark A
    J Mol Endocrinol; 2017 Oct; 59(3):R121-R140. PubMed ID: 28811318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human IAPP amyloidogenic properties and pancreatic β-cell death.
    Fernández MS
    Cell Calcium; 2014 Nov; 56(5):416-27. PubMed ID: 25224501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetracycline treatment retards the onset and slows the progression of diabetes in human amylin/islet amyloid polypeptide transgenic mice.
    Aitken JF; Loomes KM; Scott DW; Reddy S; Phillips AR; Prijic G; Fernando C; Zhang S; Broadhurst R; L'Huillier P; Cooper GJ
    Diabetes; 2010 Jan; 59(1):161-71. PubMed ID: 19794060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Cholesterol and Phospholipids in Amylin Misfolding, Aggregation and Etiology of Islet Amyloidosis.
    Singh S; Trikha S; Bhowmick DC; Sarkar AA; Jeremic AM
    Adv Exp Med Biol; 2015; 855():95-116. PubMed ID: 26149927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myricetin protects pancreatic β-cells from human islet amyloid polypeptide (hIAPP) induced cytotoxicity and restores islet function.
    Dubey R; Kulkarni SH; Dantu SC; Panigrahi R; Sardesai DM; Malik N; Acharya JD; Chugh J; Sharma S; Kumar A
    Biol Chem; 2021 Jan; 402(2):179-194. PubMed ID: 33544469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human islet amyloid polypeptide: A therapeutic target for the management of type 2 diabetes mellitus.
    Roham PH; Save SN; Sharma S
    J Pharm Anal; 2022 Aug; 12(4):556-569. PubMed ID: 36105173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Baboon IAPP Provides Insight into Amyloidogenicity and Cytotoxicity of Human IAPP.
    Ridgway Z; Lee KH; Zhyvoloup A; Wong A; Eldrid C; Hannaberry E; Thalassinos K; Abedini A; Raleigh DP
    Biophys J; 2020 Mar; 118(5):1142-1151. PubMed ID: 32105649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clustering and internalization of toxic amylin oligomers in pancreatic cells require plasma membrane cholesterol.
    Trikha S; Jeremic AM
    J Biol Chem; 2011 Oct; 286(41):36086-36097. PubMed ID: 21865171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TPE conjugated islet amyloid polypeptide probe for detection of peptide oligomers.
    Tsai HC; Huang CH; Tu LH
    Biophys Chem; 2024 Jan; 304():107129. PubMed ID: 37948788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective.
    Brender JR; Salamekh S; Ramamoorthy A
    Acc Chem Res; 2012 Mar; 45(3):454-62. PubMed ID: 21942864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of proteolytically stable N-methylated peptide inhibitors of aggregation of the amylin peptide implicated in type 2 diabetes.
    Obasse I; Taylor M; Fullwood NJ; Allsop D
    Interface Focus; 2017 Dec; 7(6):20160127. PubMed ID: 29147551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IAPP/amylin and β-cell failure: implication of the risk factors of type 2 diabetes.
    Kanatsuka A; Kou S; Makino H
    Diabetol Int; 2018 Jul; 9(3):143-157. PubMed ID: 30603362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.